Skip to content
Contactez-nous: (+33) 1 64 62 10 12
Home
Company
About us
Our history
Our management team
Know-how
Privacy policy
Theranostic
Therapeutic Drug Monitoring of Biologics
When to perform TDM ?
Results interpretation
Therapeutic Thresholds
Tracker Publications
Guidelines
Frequently asked questions
TRACKER
LISA TRACKER
i-Tracker
i-Track 10
ez-Track1 & ez-Tracker
Immunotrol Tracker
Diagnostics
Autoimmunity
Reagents – Autoimmunity
Quality Control – Auto-Immunity
Other fields
Instrumentation
Theralis
FIDIS™
Services
Technical Documentation Download Center
News
Press Releases
List of upcoming events
Congress calendar
Contacts
Menu
Close
Shareholding
Home
>
Investors
>
Shareholder information
>
Shareholding
Last update on April 7th, 2023
[wpdatatable id=91]
Home
Company
About us
Our history
Our management team
Know-how
Privacy policy
Theranostic
Therapeutic Drug Monitoring of Biologics
When to perform TDM ?
Results interpretation
Therapeutic Thresholds
Tracker Publications
Guidelines
Frequently asked questions
TRACKER
LISA TRACKER
i-Tracker
i-Track 10
ez-Track1 & ez-Tracker
Immunotrol Tracker
Diagnostics
Autoimmunity
Reagents – Autoimmunity
Quality Control – Auto-Immunity
Other fields
Instrumentation
Theralis
FIDIS™
Services
Technical Documentation Download Center
News
Press Releases
List of upcoming events
Congress calendar
Contacts
